SCHEMBL8666068

SCHEMBL8666068

C1CC(C2CCO2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12906709 0.94
SCHEMBL19550911 0.94
SCHEMBL124218 0.94
SCHEMBL122714 0.94
SCHEMBL11377504 0.94
SCHEMBL8173625 0.94
SCHEMBL19551074 0.94
SCHEMBL9987268 0.90 ALDH1A1 (0.41)
SCHEMBL128736 0.88
SCHEMBL216077 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019192533-A1 ESTROGEN RECEPTOR DEGRADING AGENT FOR TREATING BREAST CANCER 深圳福沃药业有限公司 2019-10-10 WO claimed
EP-0880503-A1 BALANOL ANALOGUES Phytera Symbion ApS (DK) 1998-12-02 EP disclosed
WO-1997029091-A1 BALANOL ANALOGUES PHYTERA SYMBION APS (DK) 1997-08-14 WO disclosed